Jarod Olson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jarod Olson has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Alan S. Hilibrand
Rothman Orthopaedic Institute at Thomas Jefferson University Hospital
5 shared publications - Alexander Richard Vaccaro
Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, USA
5 shared publications - Christopher K. Kepler
Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, USA
5 shared publications - Gregory Douglas Schroeder
Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, USA
5 shared publications - Jonathan Dalton
Rothman Orthopaedic Institute
5 shared publications - Mitchell K. Ng
Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, USA
5 shared publications
Latest Publications
- 11 August 2026
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
Surgical Risk and Patient-Reported Outcomes in 3- and 4-Level Anterior Cervical Discectomy and Fusion: A Comparative Study
Introduction: The existing literature on anterior cervical diskectomy and fusion (ACDF) predominantly focuses on 1- and 2-level procedures, leaving limited data comparing outcomes of 3- versus 4-level standalone ACDFs. Thus, the aim of this study was to compare surgical outcomes and patient-reported outcome measures (PROMs) of 3- versus 4-level ACDF. Methods: Patients who underwent 3- or 4-level ACDF within a single academic health system (2014 to 2020) were retrospectively identified. Surgical outcomes and PROMs were evaluated, including the 0 to 10 numeric rating scale for neck and arm pain, Short Form-12, Modified Japanese Orthopaedic Association (mJOA), and Neck Disability Index (NDI). Patients were excluded if they did not have complete preoperative or 1-year postoperative mJOA scores, underwent ACDF for tumor/trauma/infection, or had concomitant posterior cervical fusion. Results: A total of 256 patients were included (46 4-level ACDFs). Patients undergoing 4-level ACDF had higher BMI (30.8 vs. 28.9; P = 0.032) and a greater prevalence of myelopathy (45.7% vs. 33.3%; P = 0.018) but were otherwise demographically similar to 3-level ACDF patients. Four-level ACDF patients had a higher dysphagia rate (20% vs. 8.6%; P = 0.033) and a higher 30-day ED visit rate (6.5% vs. 0%; P = 0.005) but similar readmission rates and all other surgical outcomes. Patients with 4-level ACDF had better 6-month NDI scores but worse 1-year mJOA scores. All other PROM comparisons and deltas were similar at all time points. Conclusion: Patients undergoing 4-level ACDF had higher BMI and a greater prevalence of myelopathy than those undergoing 3-level ACDF; 4-level ACDF was associated with a higher rate of dysphagia and early postoperative ED utilization, but not readmissions. The groups otherwise did similarly with respect to surgical outcomes and PROM improvements. These findings suggest that extending fusion from three to four levels was not associated with increased surgical risk or inferior short-term functional or pain outcomes compared with 3-level ACDF.
- 11 August 2026
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
Surgical Risk and Patient-Reported Outcomes in 3- and 4-Level Anterior Cervical Discectomy and Fusion: A Comparative Study
Introduction: The existing literature on anterior cervical diskectomy and fusion (ACDF) predominantly focuses on 1- and 2-level procedures, leaving limited data comparing outcomes of 3- versus 4-level standalone ACDFs. Thus, the aim of this study was to compare surgical outcomes and patient-reported outcome measures (PROMs) of 3- versus 4-level ACDF. Methods: Patients who underwent 3- or 4-level ACDF within a single academic health system (2014 to 2020) were retrospectively identified. Surgical outcomes and PROMs were evaluated, including the 0 to 10 numeric rating scale for neck and arm pain, Short Form-12, Modified Japanese Orthopaedic Association (mJOA), and Neck Disability Index (NDI). Patients were excluded if they did not have complete preoperative or 1-year postoperative mJOA scores, underwent ACDF for tumor/trauma/infection, or had concomitant posterior cervical fusion. Results: A total of 256 patients were included (46 4-level ACDFs). Patients undergoing 4-level ACDF had higher BMI (30.8 vs. 28.9; P = 0.032) and a greater prevalence of myelopathy (45.7% vs. 33.3%; P = 0.018) but were otherwise demographically similar to 3-level ACDF patients. Four-level ACDF patients had a higher dysphagia rate (20% vs. 8.6%; P = 0.033) and a higher 30-day ED visit rate (6.5% vs. 0%; P = 0.005) but similar readmission rates and all other surgical outcomes. Patients with 4-level ACDF had better 6-month NDI scores but worse 1-year mJOA scores. All other PROM comparisons and deltas were similar at all time points. Conclusion: Patients undergoing 4-level ACDF had higher BMI and a greater prevalence of myelopathy than those undergoing 3-level ACDF; 4-level ACDF was associated with a higher rate of dysphagia and early postoperative ED utilization, but not readmissions. The groups otherwise did similarly with respect to surgical outcomes and PROM improvements. These findings suggest that extending fusion from three to four levels was not associated with increased surgical risk or inferior short-term functional or pain outcomes compared with 3-level ACDF.
- Open Access
- 14 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-9
Well-controlled asthma does not adversely affect outcomes following anterior cervical discectomy and fusion
Study Design: Retrospective Cohort Study. Objective: Recent studies have explored the negative impact that respiratory conditions have on outcomes after anterior discectomy and fusion (ACDF). However, the impact that asthmatic status has on postoperative outcomes remains unclear. The purpose of this study was to compare postoperative outcomes between patients with and without asthma who undergo ACDF. Methods: Patients who underwent a primary, elective 1–4 level ACDF (2014–2020) with complete preoperative and 1-year postoperative Neck Disability Index (NDI) surveys were identified. Asthmatic status was determined and stratified into severity. Demographic, comorbidity, perioperative, and PROM data were collected. PROMs included the Visual Analog Scale (VAS) Neck and Arm, Mental Component Summary (MCS), Physical Component Summary (PCS), Modified Japanese Orthopaedic Association (mJOA) score, and NDI. Each PROM was assessed preoperatively and postoperatively at 12 months, with P < 0.05 considered significant. Results: 1195 patients were included (81 (6.78%) had a history of asthma and 1114 (93.2%) did not). Of the asthmatic patients, 37 (45.8%) had well-controlled asthma and 44 (54.3%) had controlled asthma. Asthmatic patients were younger (52.7 vs. 56.1, P = 0.008) and had higher CCI scores (1.04 vs. 0.52, P < 0.001). There were no other differences in demographic variables, ED or readmission rates, 1-year reoperation rates, or PROMs between groups. Conclusion: Patients with well-controlled asthma performed equally as well after anterior cervical fusion as those without asthma. Both groups had similar clinical and patient-reported outcomes, suggesting that having a preoperative diagnosis of well-controlled asthma does not increase risk of postoperative complications after ACDF. Level of Evidence: III.
- 14 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-9
Open AccessWell-controlled asthma does not adversely affect outcomes following anterior cervical discectomy and fusion
Study Design: Retrospective Cohort Study. Objective: Recent studies have explored the negative impact that respiratory conditions have on outcomes after anterior discectomy and fusion (ACDF). However, the impact that asthmatic status has on postoperative outcomes remains unclear. The purpose of this study was to compare postoperative outcomes between patients with and without asthma who undergo ACDF. Methods: Patients who underwent a primary, elective 1–4 level ACDF (2014–2020) with complete preoperative and 1-year postoperative Neck Disability Index (NDI) surveys were identified. Asthmatic status was determined and stratified into severity. Demographic, comorbidity, perioperative, and PROM data were collected. PROMs included the Visual Analog Scale (VAS) Neck and Arm, Mental Component Summary (MCS), Physical Component Summary (PCS), Modified Japanese Orthopaedic Association (mJOA) score, and NDI. Each PROM was assessed preoperatively and postoperatively at 12 months, with P < 0.05 considered significant. Results: 1195 patients were included (81 (6.78%) had a history of asthma and 1114 (93.2%) did not). Of the asthmatic patients, 37 (45.8%) had well-controlled asthma and 44 (54.3%) had controlled asthma. Asthmatic patients were younger (52.7 vs. 56.1, P = 0.008) and had higher CCI scores (1.04 vs. 0.52, P < 0.001). There were no other differences in demographic variables, ED or readmission rates, 1-year reoperation rates, or PROMs between groups. Conclusion: Patients with well-controlled asthma performed equally as well after anterior cervical fusion as those without asthma. Both groups had similar clinical and patient-reported outcomes, suggesting that having a preoperative diagnosis of well-controlled asthma does not increase risk of postoperative complications after ACDF. Level of Evidence: III.
- Open Access
- 10 April 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-11
The impact of operative level on reoperation rates and short-term patient-reported outcomes in 3-level anterior cervical discectomy and fusion
Purpose: To examine whether clinical outcomes and patient-reported outcomes (PROMs) differ when patients are stratified by operative level in 3-level ACDF procedures. Methods: In this retrospective single-institution cohort study, patients undergoing 3-level ACDF (2014–2020) were reviewed for demographics, clinical outcomes, and PROMs. Patients with operative indications of infection/cancer/trauma/deformity were excluded. Patients with incomplete preoperative or 1-year postoperative PROMs were also excluded. PROMs, including SF-12, VAS Neck, VAS Arm, mJOA, and NDI, were assessed preoperatively and at 3, 6, and 12 months postoperatively. One-year MCID achievement was calculated using established thresholds. Patients were stratified and compared by construct level (C3-C6, C4-C7, and C5-T1). Results: Patients undergoing C3–C6 fusions were older than those in the C4–C7 group (62.7 versus 58.1 years, P = 0.007). The C5–T1 cohort had a higher 2-year reoperation rate compared to the C4–C7 cohort (18.2% versus 0.77%, P = 0.048). Baseline VAS Arm scores were worse in the C4–C7 group, with greater improvement at 1 year compared to the C3–C6 group (–3.45 versus − 2.27, P = 0.047). A transient difference in NDI at 3 months resolved by 6 months. MCID achievement rates across all PROMs did not differ significantly between groups. Conclusion: In patients undergoing 3-level ACDF, the operative level was associated with reoperation rates and baseline symptom profiles. However, the likelihood of achieving clinically meaningful improvements was similar across levels. Our findings support the need for construct-specific preoperative counseling while reinforcing the overall efficacy of 3-level ACDF across cervical levels.
- 10 April 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 1-11
Open AccessThe impact of operative level on reoperation rates and short-term patient-reported outcomes in 3-level anterior cervical discectomy and fusion
Purpose: To examine whether clinical outcomes and patient-reported outcomes (PROMs) differ when patients are stratified by operative level in 3-level ACDF procedures. Methods: In this retrospective single-institution cohort study, patients undergoing 3-level ACDF (2014–2020) were reviewed for demographics, clinical outcomes, and PROMs. Patients with operative indications of infection/cancer/trauma/deformity were excluded. Patients with incomplete preoperative or 1-year postoperative PROMs were also excluded. PROMs, including SF-12, VAS Neck, VAS Arm, mJOA, and NDI, were assessed preoperatively and at 3, 6, and 12 months postoperatively. One-year MCID achievement was calculated using established thresholds. Patients were stratified and compared by construct level (C3-C6, C4-C7, and C5-T1). Results: Patients undergoing C3–C6 fusions were older than those in the C4–C7 group (62.7 versus 58.1 years, P = 0.007). The C5–T1 cohort had a higher 2-year reoperation rate compared to the C4–C7 cohort (18.2% versus 0.77%, P = 0.048). Baseline VAS Arm scores were worse in the C4–C7 group, with greater improvement at 1 year compared to the C3–C6 group (–3.45 versus − 2.27, P = 0.047). A transient difference in NDI at 3 months resolved by 6 months. MCID achievement rates across all PROMs did not differ significantly between groups. Conclusion: In patients undergoing 3-level ACDF, the operative level was associated with reoperation rates and baseline symptom profiles. However, the likelihood of achieving clinically meaningful improvements was similar across levels. Our findings support the need for construct-specific preoperative counseling while reinforcing the overall efficacy of 3-level ACDF across cervical levels.
- 9 March 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (10) , 1-9
Patients taking GLP-1 agonists for weight-loss prior to posterior lumbar decompression and fusion have similar surgical and patient-reported outcomes
- 9 March 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (10) , 1-9
Patients taking GLP-1 agonists for weight-loss prior to posterior lumbar decompression and fusion have similar surgical and patient-reported outcomes
- 2 March 2026
- Published by Wolters Kluwer Health in Clinical Spine Surgery
The Impact of Central and Foraminal Stenosis Severity on the Need for Surgery After Epidural Steroid Injection
Study Design: Retrospective Cohort Study. Objective: This study aimed to identify radiographic and patient-dependent factors that predict failure of epidural steroid injection (ESI) management, leading to subsequent surgical management in patients with lumbar stenosis. Summary of Background Data: Lumbar stenosis is a common cause of radiculopathy and neurogenic claudication, and ESIs are a mainstay of conservative care. However, the benefits of ESIs are debated, and limited evidence exists on how stenosis characteristics correlate with the need for eventual surgery post-ESI. Methods: Adult patients (N=581) who received ESIs for lumbar radiculopathy or spinal stenosis between 2018 and 2021 were retrospectively identified. Subsequent lumbar spine surgery within two years of the first ESI was the primary outcome. Central and foraminal stenosis were graded using preoperative MRIs according to the Guen and Lee classification systems, respectively. Pre- and post-injection pain scores were collected. Multivariate logistic regression was used to determine significant independent predictors of subsequent surgery, accounting for age, body mass index (BMI), diabetes, Charlson Comorbidity Index (CCI), total number of ESIs, central stenosis, and foraminal stenosis. Results: Significant predictors of needing surgery within two years of the first ESI were age (OR 0.96; P P =0.046), diabetes (OR 2.55, 95% CI [1.31, 4.96], P =0.010), total number of ESIs received (OR 1.83, 95% CI [1.46, 2.29], P P <0.001). Central stenosis severity was not a significant predictor of surgery following ESI. Conclusions: In patients treated with initial ESI, foraminal stenosis severity predicted the need for subsequent lumbar spine surgery. Additionally, age, BMI, diabetes, and cumulative number of ESIs were identified as independent predictors of surgery. These findings may assist physicians in counseling patients about the progression of their lumbar stenosis and in predicting the need for future surgery. Level of Evidence: III
- 2 March 2026
- Published by Wolters Kluwer Health in Clinical Spine Surgery
The Impact of Central and Foraminal Stenosis Severity on the Need for Surgery After Epidural Steroid Injection
Study Design: Retrospective Cohort Study. Objective: This study aimed to identify radiographic and patient-dependent factors that predict failure of epidural steroid injection (ESI) management, leading to subsequent surgical management in patients with lumbar stenosis. Summary of Background Data: Lumbar stenosis is a common cause of radiculopathy and neurogenic claudication, and ESIs are a mainstay of conservative care. However, the benefits of ESIs are debated, and limited evidence exists on how stenosis characteristics correlate with the need for eventual surgery post-ESI. Methods: Adult patients (N=581) who received ESIs for lumbar radiculopathy or spinal stenosis between 2018 and 2021 were retrospectively identified. Subsequent lumbar spine surgery within two years of the first ESI was the primary outcome. Central and foraminal stenosis were graded using preoperative MRIs according to the Guen and Lee classification systems, respectively. Pre- and post-injection pain scores were collected. Multivariate logistic regression was used to determine significant independent predictors of subsequent surgery, accounting for age, body mass index (BMI), diabetes, Charlson Comorbidity Index (CCI), total number of ESIs, central stenosis, and foraminal stenosis. Results: Significant predictors of needing surgery within two years of the first ESI were age (OR 0.96; P P =0.046), diabetes (OR 2.55, 95% CI [1.31, 4.96], P =0.010), total number of ESIs received (OR 1.83, 95% CI [1.46, 2.29], P P <0.001). Central stenosis severity was not a significant predictor of surgery following ESI. Conclusions: In patients treated with initial ESI, foraminal stenosis severity predicted the need for subsequent lumbar spine surgery. Additionally, age, BMI, diabetes, and cumulative number of ESIs were identified as independent predictors of surgery. These findings may assist physicians in counseling patients about the progression of their lumbar stenosis and in predicting the need for future surgery. Level of Evidence: III